4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18181311 | RNAi Agents for Inhibiting Expression of DUX4, Compositions Thereof, And Methods of Use | SULLIVAN, STEPHANIE LAUREN | 1635 | Non-Final OA | Mar 09, 2023 |
| 18178242 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | ZARA, JANE J | 1637 | Non-Final OA | Mar 03, 2023 |
| 18074268 | RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION | ANGELL, JON E | 1637 | Non-Final OA | Dec 02, 2022 |
| 18048577 | RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use | VANHORN, ABIGAIL LOUISE | 1636 | Final Rejection | Oct 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial